Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2002-2026

Philips Bridge Prep Kit REF: K12-09098B Sterile EO, Rx ONLY Recall

Philips Bridge Prep Kit REF: K12-09098B Sterile EO, Rx ONLY

FDA recall Class II

Ongoing

FDA lists this Class II recall for Philips Bridge Prep Kit REF: K12-09098B Sterile EO, Rx ONLY. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2002-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Apr 2, 2026
FDA report date
May 6, 2026
Quantity in commerce
Not reported
Distribution
See key details
FDA cause
Nonconforming Material/Component

What is being recalled?

Philips Bridge Prep Kit REF: K12-09098B Sterile EO, Rx ONLY

Affected model & UDI checker

Search the exact identifiers published for Z-2002-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
K12-09098BPhilips Bridge Prep Kit REF: K12-09098B Sterile EO, Rx ONLYCheck source noticeNot specified
Not specifiedPhilips Bridge Prep Kit REF: K12-09098B Sterile EO, Rx ONLYCheck source notice00884450771310
FDA code information

All Lot Numbers/UDI: 00884450771310

View the original FDA recall notice

Why was this product recalled?

catheter may experience resistance when being advanced over the guidewire

What actions did Merit Medical Systems, Inc. take?

On April 17, 2026, Merit Medical Issued a Urgent Medical Device Recall notification via: FedEx. Initial notification was issued on April 2, 2026 via E-Mail and FedEx. Merit ask consignees to take the following actions: 1. Ensure that applicable personnel within your organization are made aware of this safety notice. 2. If the product has been further distributed to other facilities, institutions, or manufacturers, please immediately share this safety notice in accordance with your company policies. Please consider communicating the following to your customers: a. For continued safe use of the Philips Bridge" and Philips Bridge" Plus Occlusion Balloons, as outlined in the Prophylactic Directions for Use in the IFU, the following actions should be taken prior to the beginning of any procedure to confirm proper interaction between devices: i. After placement of the guidewire, advance the Balloon over the guidewire. This will confirm that the Balloon can freely be advanced over the entire length of the guidewire without resistance, thereby confirming that the guidewire is compatible with the Balloon. ii. Should resistance be felt during this step, the guidewire should be replaced with an alternate 0.035 stiff/super stiff wire, and Step 1 should be repeated prior to the beginning of the procedure. 3. Please circulate this information to all users of the Philips Bridge", Philips Bridge" Plus, and Bridge" Prep Kit device, or to any organization where the affected product may have been transferred, so that they are aware of the issue. Merit encourages you to instruct your customers to post the safety notice on or near the affected products.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology